Myeonghwan Kim

Myeonghwan Kim

Auto-generated profile, based on publicly available information

Myeonghwan Kim

Center for RNA Research, Institute for Basic Science, Seoul, Korea

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 August 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
SKSeongryong Kim
Seongryong Kim
JJJi Hyang Jeon
Ji Hyang Jeon
MKMyeonghwan Kim
Myeonghwan Kim
YLYeji Lee
Yeji Lee
YHYun-Ho Hwang
Yun-Ho Hwang
JYJinah Yeo
Jinah Yeo
MRNA vaccines against SARS-CoV-2 have revolutionized vaccine development, but their immunological mechanisms are not fully understood. Here, we investigate injection site responses of mRNA vaccines by generating a comprehensive single-cell transcriptome profile upon lipid nanoparticle (LNP) or LNP-mRNA challenge in female BALB/c mice. We show that LNP-induced stromal pro-inflammatory responses and mRNA-elicited type I interferon responses dominate the initial injection site responses. By tracking the fate of delivered mRNA, we discover that injection site fibroblasts are highly enriched with the delivered mRNA and that they express IFN-β specifically in response to the mRNA component, not to the LNP component of mRNA vaccines. Moreover, the mRNA-LNP, but not LNP alone, induces migratory dendritic cells highly expressing IFN-stimulated genes (mDC_ISGs) at the injection site and draining lymph nodes. When co-injected with LNP-subunit vaccine, IFN-β induces mDC_ISGs at the injection site, and importantly, it substantially enhances antigen-specific cellular immune responses. Furthermore, blocking IFN-β signaling at the injection site significantly decreases mRNA vaccine-induced cellular immune responses. Collectively, these data highlight the importance of injection site fibroblasts and IFN-β signaling during early immune responses against the mRNA vaccine and provide detailed information on the initial chain of immune reactions elicited by mRNA vaccine injection.

4 April 2025 in Science
Verified
Journal Article
Closed access
MKMyeonghwan Kim
Myeonghwan Kim
YPYoungjoon Pyo
Youngjoon Pyo
SHSeong-In Hyun
Seong-In Hyun
MJMinseok Jeong
Minseok Jeong
YCYeon Choi
Yeon Choi
VKV. Narry Kim
V. Narry Kim
Exogenous messenger RNAs (mRNAs) require cellular machinery for delivery and translation but also encounter inhibitory factors. To investigate their regulation, we performed genome-wide CRISPR screens with in vitro–transcribed mRNAs in lipid nanoparticles (LNPs). Heparan sulfate proteoglycans (HSPGs) and vacuolar adenosine triphosphatase (V-ATPase) were identified as mediators of LNP uptake and endosomal escape, respectively. TRIM25—an RNA binding E3 ubiquitin ligase—emerged as a key suppressor inducing turnover of both linear and circular mRNAs. The endoribonucleases N4BP1 and KHNYN, along with the antiviral protein ZAP, act redundantly in TRIM25-dependent surveillance. TRIM25 specifically targets mRNAs delivered by endosomes, and its RNA affinity increases at acidic pH, suggesting activation by protons released from ruptured endosomes. N 1 -methylpseudouridine modification reduces TRIM25’s RNA binding, helping RNAs evade its suppressive effect. This study comprehensively maps cellular pathways regulating LNP-mRNAs, offering insights into RNA immunity and therapeutics.

27 February 2023 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
PDF file
JPJoha Park
Joha Park
MKMyeonghwan Kim
Myeonghwan Kim
HYHyerim Yi
Hyerim Yi
KBKyungmin Baeg
Kyungmin Baeg
YCYongkuk Choi
Yongkuk Choi
VKV. Narry Kim
V. Narry Kim